A simple drug cocktail that converts cells neighboring damaged neurons into functional new neurons could potentially be used to treat stroke, Alzheimer’s disease, and brain injuries.
A team of researchers at Penn State identified a set of four, or even three, molecules that could convert glial cells—which normally provide support and insulation for neurons—into new neurons. A paper describing the approach appears online in the journal Stem Cell Reports on February 7, 2019.
“The biggest problem for brain repair is that neurons don’t regenerate after brain damage, because they don’t divide,” said Gong Chen, professor of biology and Verne M. Willaman Chair in Life Sciences at Penn State and leader of the research team. “In contrast, glial cells, which gather around damaged brain tissue, can proliferate after brain injury. I believe turning glial cells that are the neighbors of dead neurons into new neurons is the best way to restore lost neuronal functions.”
Chen’s team previously published research describing a sequence of nine small molecules that could directly convert human glial cells into neurons, but the large number of molecules and the specific sequence required for reprogramming the glial cells complicated the transition to a clinical treatment. In the current study, the team tested various numbers and combinations of molecules to identify a streamlined approach to the reprogramming of astrocytes, a type of glial cells, into neurons.
“We identified the most efficient chemical formula among the hundreds of drug combinations that we tested,” said Jiu-Chao Yin, a graduate student in biology at Pen State who identified the ideal combination of small molecules. “By using four molecules that modulate four critical signaling pathways in human astrocytes, we can efficiently turn human astrocytes—as many as 70 percent—into functional neurons.”
The resulting chemically converted neurons can survive more than seven months in a culture dish in the lab. They form robust neural networks and send chemical and electrical signals to each other, as normal neurons do inside the brain.
Using three of the small molecules instead of four also results in the conversion of astrocytes into neurons, but the conversion rate drops by about 20 percent. The team also tried using only one of the molecules, but this approach did not induce conversion.
Chen and his team had previously developed a gene therapy technology to convert astrocytes into functional neurons, but due to the excessive cost of gene therapy—which can cost a patient half a million dollars or more—the team has been pursuing more economical approaches to convert glial cells into neurons. The delivery system for gene therapies is also more complex, requiring the injection of viral particles into the human body, whereas the small molecules in the new method can be chemically synthesized and packaged into a pill.
“The most significant advantage of the new approach is that a pill containing small molecules could be distributed widely in the world, even reaching rural areas without advanced hospital systems,” said Chen. “My ultimate dream is to develop a simple drug delivery system, like a pill, that can help stroke and Alzheimer’s patients around the world to regenerate new neurons and restore their lost learning and memory capabilities.”
The researchers acknowledge that many technical issues still need to be resolved before a drug using small molecules could be created, including the specifics of drug packaging and delivery. They also plan to investigate potential side effects of this approach in future studies in order to develop the safest drug pills. Nonetheless, the research team is confident that this combination of molecules has promising implications for future drug therapies to treat individuals with neurological disorders.
“Our years of effort in discovering this simplified drug formula take us one step closer to reaching our dream,” said Chen.
The Latest on: Small molecules
via Google News
The Latest on: Small molecules
- Eisai, Wren Therapeutics ink research agreement to advance discovery of novel small molecules targeting alpha-synuclein to treat synucleinopathieson November 30, 2020 at 11:30 pm
Eisai, Wren Therapeutics ink research agreement to advance discovery of novel small molecules targeting alpha-synuclein to treat synucleinopathies: Tokyo Tuesday, December 1, 2020 ...
- Small molecules control bacterial resistance to antibioticson November 30, 2020 at 7:30 am
Antibiotics have revolutionized medicine by providing effective treatments for infectious diseases such as cholera. But the pathogens that cause disease are increasingly developing resistance to the ...
- Weird 'gravitational Molecules' Could Orbit Black Holes Like Electrons Orbiting Atomson November 30, 2020 at 6:12 am
Unnatural Black gravitational molecules found swirling around black holes like electrons orbiting atoms of atoms. Read about this discovery in this article.
- Small molecules could hold the key to enhancing the efficiency of organic solar cellson November 24, 2020 at 6:22 am
Understanding how particles travel through a device is vital for improving the efficiency of solar cells. Researchers from KAUST, working with an international team of scientists, have now developed a ...
- Outlook on the Bio CMO Global Market to 2024 - Preference of Biologics Over Small Molecules is Driving Growthon November 23, 2020 at 2:55 am
Size & Forecasts with Impact Analysis of COVID-19 (2020-2024 Edition)" report has been added to ResearchAndMarkets.com's offering. This report provides an analysis of the global bio CMO market, with ...
- Sosei Heptares' COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Developmenton November 20, 2020 at 1:25 am
PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) announces a progress update for its R&D program focused on the design and development of novel drugs targeting the SARS-CoV-2 ...
- Sosei Heptares’ COVID-19 programme advances promising moleculeson November 20, 2020 at 12:46 am
Japanese pharma company Sosei Heptares has identified and advanced the ‘most promising’ molecules in its COVID-19 research and development programme. Sosei initiated the R&D programme back in April, ...
- Raman microscopy-based approach uses gold nanoparticles for visualizing small-molecule drugson November 19, 2020 at 9:36 pm
Successful drug development has a significant impact on people's quality of life worldwide. Being able to track how molecules get into target cells, and observing what they do when they are inside, is ...
- New Microscopy Approach to Observe Dynamics of Small-Molecule Drugs in Cellson November 19, 2020 at 5:45 am
The quality of life of people around the world has been considerably influenced by successful drug development.
- Shutting down COVID-19 virus' destructive proteins with aerosolized moleculeson November 12, 2020 at 4:00 pm
Researchers have successfully used molecules made up of small strands of RNA to shut down the production of destructive proteins generated by the COVID-19 virus. Additionally, the researchers are ...
via Bing News